Ribociclib Nanostructured Lipid Carrier Aimed for Breast Cancer: Formulation Optimization, Attenuating In Vitro Specification, and In Vivo Scrutinization.
Ali Sartajnull AnnuLargee BiswasAnita Kamra VermaP K SahooSanjula BabootaJaved AliPublished in: BioMed research international (2022)
results showed a prominent potential for bioavailability enhancement of RBO and effective breast cancer therapy.